Optimizing Radiation Oncology Prior Authorization Automation

Klivira delivers comprehensive **radiation oncology prior authorization automation**, streamlining the complex process for high-cost therapies and enhancing patient access to critical care.

For radiation oncology departments, the administrative burden of prior authorizations for advanced therapies like IMRT and proton beam therapy can significantly delay care and strain revenue cycles. Manual workflows lead to missed PAs, documentation gaps, and costly denials, diverting valuable clinical time and impacting patient outcomes. Klivira addresses these challenges by automating the entire PA lifecycle.

The Unique PA Challenges in Radiation Oncology

Radiation oncology treatments often involve high-cost, technologically advanced therapies such as Intensity-Modulated Radiation Therapy (IMRT), proton beam therapy, Stereotactic Body Radiation Therapy (SBRT), and brachytherapy. These procedures are frequently subject to stringent prior authorization requirements from payers, necessitating detailed clinical documentation and adherence to specific medical policies. The complexity of these cases, coupled with the urgency of cancer treatment, makes efficient PA crucial.

EMR-Integrated Detection for Radiation Therapy Orders

Klivira's platform integrates directly with your EMR (e.g., Epic, Cerner) via SMART on FHIR and CDS Hooks, enabling real-time prior authorization requirement detection at the point of order entry. When a radiation oncologist orders IMRT or proton beam therapy, the system immediately assesses payer-specific rules using Da Vinci CRD-style discovery. This proactive approach eliminates missed PA-required orders, a common failure point in manual workflows.

Automated Documentation for Complex Cases

Assembling the comprehensive clinical documentation required for radiation oncology PAs—including staging reports, treatment plans, imaging results, and physician notes—is a time-intensive process. Klivira leverages FHIR resources (e.g., DocumentReference, DiagnosticReport) to automatically pull relevant data from the EMR. For payers supporting Da Vinci DTR, the system can further streamline data collection through structured questionnaires, ensuring complete and accurate submissions for therapies like SBRT and brachytherapy.

Payer-Specific Submission and Tracking for Radiotherapy

Klivira intelligently routes radiation oncology PA requests through the optimal channel for each payer and benefit category. This includes Da Vinci PAS API for supported payers, X12 278 via clearinghouses, or direct provider portal automation. Real-time status polling and webhook integration provide continuous updates, eliminating "status unknown" cases and enabling timely follow-up for critical treatments, adhering to decision timeframes like those outlined in CMS-0057-F.

Expedited Denial Management and Appeals

Denials for radiation oncology treatments can severely impact patient care pathways and revenue. Klivira automates the parsing of denial reasons (e.g., X12 CARC/RARC codes) and facilitates expedited appeals. For clinical-necessity denials, the platform assists in auto-assembling appeal packets based on NCCN, ACR, or ASCO guidelines, tracks timely-filing windows, and routes cases for human review or peer-to-peer scheduling when clinical judgment is essential.

Transforming Radiation Oncology PA Workflows

Eliminate missed PA requirements for IMRT, proton beam, SBRT, and brachytherapy.
Reduce administrative burden on PA coordinators and clinical staff.
Accelerate patient access to critical radiation therapies.
Improve first-pass approval rates and reduce denial volumes.
Ensure accurate authorization numbers are written back to the EMR for billing.
Maintain compliance with payer-specific policies and federal mandates like CMS-0057-F.

Frequently asked questions

Which specific radiation oncology procedures benefit most from prior authorization automation?

High-cost and complex radiation therapies such as IMRT, proton beam therapy, Stereotactic Body Radiation Therapy (SBRT), and brachytherapy are primary beneficiaries. These procedures frequently trigger prior authorization requirements, making their automated management critical for efficiency and patient access.

How does Klivira integrate with our existing EMR for radiation oncology orders?

Klivira integrates using industry standards like SMART on FHIR and CDS Hooks for real-time detection at order entry. This allows the system to identify PA requirements immediately when a radiation oncologist places an order, pulling relevant clinical data directly from the patient chart to build the authorization request.

Can Klivira's platform handle appeals for denied radiation therapy authorizations?

Yes, Klivira automates a significant portion of the appeal workflow. It parses denial reasons, helps assemble appeal packets with supporting clinical evidence (often guided by NCCN or ASCO guidelines), tracks timely-filing deadlines, and facilitates routing for human review or peer-to-peer consultations when necessary.

What payer communication channels does Klivira use for radiation oncology prior authorizations?

Klivira utilizes a multi-channel approach, prioritizing electronic methods. This includes Da Vinci PAS APIs for payers that support them, X12 278 for EDI-capable payers, direct provider portal automation, and fax as a last-resort fallback. This ensures optimal routing for all radiation therapy requests.

How does Klivira ensure the authorization number gets back into our EMR for billing?

Upon approval, Klivira automatically writes the authorization number back to the EMR. This is typically achieved via a FHIR DocumentReference write or an EMR-specific order update mechanism, ensuring that the authorization number is correctly associated with the order for downstream billing and claims submission.